Sabine Bahn

Affiliations: 
Chemical Engineering and Biotechnology University of Cambridge, Cambridge, England, United Kingdom 
Area:
molecular mechanisms of psychiatric diseases
Google:
"Sabine Bahn"
Mean distance: 15087
 
Cross-listing: Computational Biology Tree - Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lago SG, Tomasik J, van Rees GF, et al. (2022) Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia. Brain, Behavior, and Immunity. 103: 37-49
Lago SG, Tomasik J, van Rees GF, et al. (2020) Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum. Brain, Behavior, and Immunity
Han SYS, Tomasik J, Rustogi N, et al. (2020) Diagnostic prediction model development using data from dried blood spot proteomics and a digital mental health assessment to identify major depressive disorder among individuals presenting with low mood. Brain, Behavior, and Immunity
Olmert T, Cooper JD, Han SYS, et al. (2020) A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational Study. Jmir Research Protocols. 9: e18453
Kittel-Schneider S, Hahn T, Haenisch F, et al. (2020) Proteomic Profiling as a Diagnostic Biomarker for Discriminating Between Bipolar and Unipolar Depression. Frontiers in Psychiatry. 11: 189
Han SYS, Cooper JD, Ozcan S, et al. (2019) Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals. Translational Psychiatry. 9: 277
Steiner J, Frodl T, Schiltz K, et al. (2019) Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment. Schizophrenia Bulletin
Çakici N, Bot M, Lamers F, et al. (2019) Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Lago SG, Tomasik J, van Rees GF, et al. (2019) Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo. Science Advances. 5: eaau9093
Tomasik J, Lago SG, Vázquez-Bourgon J, et al. (2019) Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment. Jama Psychiatry
See more...